The Epistemology of a Positive SARS-CoV-2 Test

被引:0
作者
Rainer Johannes Klement
Prasanta S. Bandyopadhyay
机构
[1] Leopoldina Hospital Schweinfurt,Department of Radiotherapy and Radiation Oncology
[2] Montana State University,Department of History & Philosophy
来源
Acta Biotheoretica | 2021年 / 69卷
关键词
Bayesianism; Confirmation; COVID-19; Evidence; RT-qPCR;
D O I
暂无
中图分类号
学科分类号
摘要
We investigate the epistemological consequences of a positive polymerase chain reaction SARS-CoV test for two relevant hypotheses: (i) V is the hypothesis that an individual has been infected with SARS-CoV-2; (ii) C is the hypothesis that SARS-CoV-2 is the cause of flu-like symptoms in a given patient. We ask two fundamental epistemological questions regarding each hypothesis: First, how much confirmation does a positive test lend to each hypothesis? Second, how much evidence does a positive test provide for each hypothesis against its negation? We respond to each question within a formal Bayesian framework. We construe degree of confirmation as the difference between the posterior probability of the hypothesis and its prior, and the strength of evidence for a hypothesis against its alternative in terms of their likelihood ratio. We find that test specificity—and coinfection probabilities when making inferences about C—were key determinants of confirmation and evidence. Tests with < 87% specificity could not provide strong evidence (likelihood ratio > 8) for V against ¬V regardless of sensitivity. Accordingly, low specificity tests could not provide strong evidence in favor of C in all plausible scenarios modeled. We also show how a positive influenza A test disconfirms C and provides weak evidence against C in dependence on the probability that the patient is influenza A infected given that his/her symptoms are not caused by SARS-CoV-2. Our analysis points out some caveats that should be considered when attributing symptoms or death of a positively tested patient to SARS-CoV-2.
引用
收藏
页码:359 / 375
页数:16
相关论文
共 238 条
  • [11] Liu T-C(2020)Profiling early humoral response to diagnose novel coronavirus disease (COVID-19) Clin Infect Dis 90 773-5
  • [12] Ng W-T(2005)Degree-of-belief and degree-of-support: why Bayesians need both notions Mind 24 4-125
  • [13] Huang H-H(2020)Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children Clin Chem Lab Med 4 50-96
  • [14] Lin P(1995)Bayes factors J Am Stat Assoc 27 95-908
  • [15] Taiwan BL(2020)Rates of co-infection between SARS-CoV-2 and other respiratory pathogens JAMA 2 69-609
  • [16] Colson V(2019)Emergence and evidence: a close look at Bunge’s philosophy of medicine Philosophies 92 903-175
  • [17] Scola L(2006)The real-time polymerase chain reaction Mol Aspects Med 63 606-431
  • [18] Esteves-Vieira C(2020)Testing for SARS-CoV-2 in cellular components by routine nested RT-PCR followed by DNA sequencing Int J Geriatr Rehabil 505 172-16
  • [19] Ninove M-T(2020)Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19 J Med Virol 69 428-20
  • [20] Zandotti VM(2020)Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients Sci China Life Sci 27 taaa054-27150